Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.64 USD | -2.76% |
|
-11.27% | -8.96% |
06-24 | Leerink Partners Upgrades Solid Biosciences to Outperform From Market Perform, Price Target is $12 | MT |
06-21 | Top Premarket Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.96% | 223M | |
+16.57% | 122B | |
+21.60% | 116B | |
+22.18% | 27.03B | |
-21.32% | 20.36B | |
-16.89% | 16.43B | |
-17.97% | 15.91B | |
-44.74% | 15.6B | |
+61.97% | 14.94B | |
+3.50% | 13.59B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Transcript : Solid Biosciences Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 09